Cargando…

Diagnostic accuracy of copeptin sensitivity and specificity in patients with suspected non-ST-elevation myocardial infarction with troponin I below the 99th centile at presentation

OBJECTIVE: To determine whether copeptin-us can rule out diagnosis of non-ST-segment elevation myocardial infarction (NSTEMI) without prolonged monitoring and serial blood sampling in patients with high-sensitive cardiac troponin I (hs-cTnT) below the 99th centile at presentation to the emergency de...

Descripción completa

Detalles Bibliográficos
Autores principales: Duchenne, Jonathan, Mestres, Stéphanie, Dublanchet, Nicolas, Combaret, Nicolas, Marceau, Geoffroy, Caumon, Laurent, Dutoit, Laurent, Ughetto, Sylvie, Motreff, Pascal, Sapin, Vincent, Schmidt, Jeannot
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975746/
https://www.ncbi.nlm.nih.gov/pubmed/24662448
http://dx.doi.org/10.1136/bmjopen-2013-004449
_version_ 1782310186070835200
author Duchenne, Jonathan
Mestres, Stéphanie
Dublanchet, Nicolas
Combaret, Nicolas
Marceau, Geoffroy
Caumon, Laurent
Dutoit, Laurent
Ughetto, Sylvie
Motreff, Pascal
Sapin, Vincent
Schmidt, Jeannot
author_facet Duchenne, Jonathan
Mestres, Stéphanie
Dublanchet, Nicolas
Combaret, Nicolas
Marceau, Geoffroy
Caumon, Laurent
Dutoit, Laurent
Ughetto, Sylvie
Motreff, Pascal
Sapin, Vincent
Schmidt, Jeannot
author_sort Duchenne, Jonathan
collection PubMed
description OBJECTIVE: To determine whether copeptin-us can rule out diagnosis of non-ST-segment elevation myocardial infarction (NSTEMI) without prolonged monitoring and serial blood sampling in patients with high-sensitive cardiac troponin I (hs-cTnT) below the 99th centile at presentation to the emergency department (ED). DESIGN: Prospective, non-randomised, individual blinded diagnostic accuracy study. SETTING: Two EDs of a rural region of France. PARTICIPANTS: Patients with chest pain suspected of NSTEMI with onset within the last 12 h were considered for enrolment. INTERVENTIONS: Serial clinical, electrographical and biochemical investigations were performed at admission and after 2, 4, 6 and 12 h. Hs-cTnT was measured using an assay with Dimension VISTA, Siemens. Copeptin was measured by the BRAHMS copeptin-us assay on the KRYPTOR Compact Plus system. The follow-up period was 90 days. PRIMARY AND SECONDARY OUTCOME MEASURES: Copeptin, troponin, myoglobin and creatine kinase values. Clinical and paraclinical events. The final diagnosis was adjudicated blinded to copeptin result. RESULTS: During 12 months, 102 patients were analysed. Final diagnosis was NSTEMI for 7.8% (n=8), unstable angina for 3.9% (n=4), cardiac but non-coronary artery disease for 8.8% (n=9), non-cardiac chest pain for 52% (n=53) and unknown for 27.5% (n=28). There was no statistical difference for copeptin values between patients with NSTEMI and others (respectively 5.5 pmol/L IQR (3.1–7.9) and 6.5 pmol/L IQR (3.9–12.1), p=0.49). Only one patient with NSTEMI had a copeptin value above the cut-off of 95th centile at admission. CONCLUSIONS: In this study, copeptin does not add a diagnostic value at admission to ED for patients with suspected acute coronary syndrome without ST-segment elevation and with hs-cTnT below the 99th centile. TRIAL REGISTRATION NUMBER: Clinicaltrials.gov identifier: NCT01334645.
format Online
Article
Text
id pubmed-3975746
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-39757462014-04-07 Diagnostic accuracy of copeptin sensitivity and specificity in patients with suspected non-ST-elevation myocardial infarction with troponin I below the 99th centile at presentation Duchenne, Jonathan Mestres, Stéphanie Dublanchet, Nicolas Combaret, Nicolas Marceau, Geoffroy Caumon, Laurent Dutoit, Laurent Ughetto, Sylvie Motreff, Pascal Sapin, Vincent Schmidt, Jeannot BMJ Open Emergency Medicine OBJECTIVE: To determine whether copeptin-us can rule out diagnosis of non-ST-segment elevation myocardial infarction (NSTEMI) without prolonged monitoring and serial blood sampling in patients with high-sensitive cardiac troponin I (hs-cTnT) below the 99th centile at presentation to the emergency department (ED). DESIGN: Prospective, non-randomised, individual blinded diagnostic accuracy study. SETTING: Two EDs of a rural region of France. PARTICIPANTS: Patients with chest pain suspected of NSTEMI with onset within the last 12 h were considered for enrolment. INTERVENTIONS: Serial clinical, electrographical and biochemical investigations were performed at admission and after 2, 4, 6 and 12 h. Hs-cTnT was measured using an assay with Dimension VISTA, Siemens. Copeptin was measured by the BRAHMS copeptin-us assay on the KRYPTOR Compact Plus system. The follow-up period was 90 days. PRIMARY AND SECONDARY OUTCOME MEASURES: Copeptin, troponin, myoglobin and creatine kinase values. Clinical and paraclinical events. The final diagnosis was adjudicated blinded to copeptin result. RESULTS: During 12 months, 102 patients were analysed. Final diagnosis was NSTEMI for 7.8% (n=8), unstable angina for 3.9% (n=4), cardiac but non-coronary artery disease for 8.8% (n=9), non-cardiac chest pain for 52% (n=53) and unknown for 27.5% (n=28). There was no statistical difference for copeptin values between patients with NSTEMI and others (respectively 5.5 pmol/L IQR (3.1–7.9) and 6.5 pmol/L IQR (3.9–12.1), p=0.49). Only one patient with NSTEMI had a copeptin value above the cut-off of 95th centile at admission. CONCLUSIONS: In this study, copeptin does not add a diagnostic value at admission to ED for patients with suspected acute coronary syndrome without ST-segment elevation and with hs-cTnT below the 99th centile. TRIAL REGISTRATION NUMBER: Clinicaltrials.gov identifier: NCT01334645. BMJ Publishing Group 2014-03-24 /pmc/articles/PMC3975746/ /pubmed/24662448 http://dx.doi.org/10.1136/bmjopen-2013-004449 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/
spellingShingle Emergency Medicine
Duchenne, Jonathan
Mestres, Stéphanie
Dublanchet, Nicolas
Combaret, Nicolas
Marceau, Geoffroy
Caumon, Laurent
Dutoit, Laurent
Ughetto, Sylvie
Motreff, Pascal
Sapin, Vincent
Schmidt, Jeannot
Diagnostic accuracy of copeptin sensitivity and specificity in patients with suspected non-ST-elevation myocardial infarction with troponin I below the 99th centile at presentation
title Diagnostic accuracy of copeptin sensitivity and specificity in patients with suspected non-ST-elevation myocardial infarction with troponin I below the 99th centile at presentation
title_full Diagnostic accuracy of copeptin sensitivity and specificity in patients with suspected non-ST-elevation myocardial infarction with troponin I below the 99th centile at presentation
title_fullStr Diagnostic accuracy of copeptin sensitivity and specificity in patients with suspected non-ST-elevation myocardial infarction with troponin I below the 99th centile at presentation
title_full_unstemmed Diagnostic accuracy of copeptin sensitivity and specificity in patients with suspected non-ST-elevation myocardial infarction with troponin I below the 99th centile at presentation
title_short Diagnostic accuracy of copeptin sensitivity and specificity in patients with suspected non-ST-elevation myocardial infarction with troponin I below the 99th centile at presentation
title_sort diagnostic accuracy of copeptin sensitivity and specificity in patients with suspected non-st-elevation myocardial infarction with troponin i below the 99th centile at presentation
topic Emergency Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975746/
https://www.ncbi.nlm.nih.gov/pubmed/24662448
http://dx.doi.org/10.1136/bmjopen-2013-004449
work_keys_str_mv AT duchennejonathan diagnosticaccuracyofcopeptinsensitivityandspecificityinpatientswithsuspectednonstelevationmyocardialinfarctionwithtroponinibelowthe99thcentileatpresentation
AT mestresstephanie diagnosticaccuracyofcopeptinsensitivityandspecificityinpatientswithsuspectednonstelevationmyocardialinfarctionwithtroponinibelowthe99thcentileatpresentation
AT dublanchetnicolas diagnosticaccuracyofcopeptinsensitivityandspecificityinpatientswithsuspectednonstelevationmyocardialinfarctionwithtroponinibelowthe99thcentileatpresentation
AT combaretnicolas diagnosticaccuracyofcopeptinsensitivityandspecificityinpatientswithsuspectednonstelevationmyocardialinfarctionwithtroponinibelowthe99thcentileatpresentation
AT marceaugeoffroy diagnosticaccuracyofcopeptinsensitivityandspecificityinpatientswithsuspectednonstelevationmyocardialinfarctionwithtroponinibelowthe99thcentileatpresentation
AT caumonlaurent diagnosticaccuracyofcopeptinsensitivityandspecificityinpatientswithsuspectednonstelevationmyocardialinfarctionwithtroponinibelowthe99thcentileatpresentation
AT dutoitlaurent diagnosticaccuracyofcopeptinsensitivityandspecificityinpatientswithsuspectednonstelevationmyocardialinfarctionwithtroponinibelowthe99thcentileatpresentation
AT ughettosylvie diagnosticaccuracyofcopeptinsensitivityandspecificityinpatientswithsuspectednonstelevationmyocardialinfarctionwithtroponinibelowthe99thcentileatpresentation
AT motreffpascal diagnosticaccuracyofcopeptinsensitivityandspecificityinpatientswithsuspectednonstelevationmyocardialinfarctionwithtroponinibelowthe99thcentileatpresentation
AT sapinvincent diagnosticaccuracyofcopeptinsensitivityandspecificityinpatientswithsuspectednonstelevationmyocardialinfarctionwithtroponinibelowthe99thcentileatpresentation
AT schmidtjeannot diagnosticaccuracyofcopeptinsensitivityandspecificityinpatientswithsuspectednonstelevationmyocardialinfarctionwithtroponinibelowthe99thcentileatpresentation